These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 16231140

  • 1. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O, Wilop S, Lüders C, Jost E, Gehbauer G, Herman JG, Osieka R.
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [Abstract] [Full Text] [Related]

  • 2. Gene methylation in gastric cancer.
    Qu Y, Dang S, Hou P.
    Clin Chim Acta; 2013 Sep 23; 424():53-65. PubMed ID: 23669186
    [Abstract] [Full Text] [Related]

  • 3. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
    Shimamoto T, Ohyashiki JH, Ohyashiki K.
    Leuk Res; 2005 Jun 23; 29(6):653-9. PubMed ID: 15863205
    [Abstract] [Full Text] [Related]

  • 4. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
    Melki JR, Vincent PC, Clark SJ.
    Cancer Res; 1999 Aug 01; 59(15):3730-40. PubMed ID: 10446989
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman JG, Osieka R, Galm O.
    Br J Haematol; 2008 Sep 01; 142(5):745-53. PubMed ID: 18537968
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P, Ji M, Yang B, Chen Z, Qiu J, Shi X, Lu Z.
    Cancer; 2006 Apr 01; 106(7):1602-9. PubMed ID: 16502411
    [Abstract] [Full Text] [Related]

  • 7. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O.
    Leuk Res; 2009 Mar 01; 33(3):443-9. PubMed ID: 18757096
    [Abstract] [Full Text] [Related]

  • 8. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K.
    Ann Surg Oncol; 2005 May 01; 12(5):354-63. PubMed ID: 15915369
    [Abstract] [Full Text] [Related]

  • 9. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 10. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O, Herman JG, Baylin SB.
    Blood Rev; 2006 Jan 01; 20(1):1-13. PubMed ID: 16426940
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [Abstract] [Full Text] [Related]

  • 12. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
    Chim CS, Tam CY, Liang R, Kwong YL.
    Cancer; 2001 Jun 15; 91(12):2222-9. PubMed ID: 11413509
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS, Wong AS, Kwong YL.
    Ann Hematol; 2003 Dec 15; 82(12):738-42. PubMed ID: 14513284
    [Abstract] [Full Text] [Related]

  • 14. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 15; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 15. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N.
    Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4403-6. PubMed ID: 17898258
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K, Kubo Y, Ohtani N, Hara E, Arase S.
    Br J Dermatol; 2006 Nov 15; 155(5):999-1005. PubMed ID: 17034532
    [Abstract] [Full Text] [Related]

  • 17. Aberrant gene promoter methylation in plasma cell dyscrasias.
    Martin P, Garcia-Cosio M, Santon A, Bellas C.
    Exp Mol Pathol; 2008 Jun 15; 84(3):256-61. PubMed ID: 18410922
    [Abstract] [Full Text] [Related]

  • 18. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M.
    Oncogene; 2002 Aug 12; 21(35):5427-40. PubMed ID: 12154405
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P, Bello MJ, Arjona D, Lomas J, Alonso ME, De Campos JM, Vaquero J, Isla A, Gutierrez M, Rey JA.
    Int J Oncol; 2003 Mar 12; 22(3):601-8. PubMed ID: 12579314
    [Abstract] [Full Text] [Related]

  • 20. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 12; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.